BNR Earnings — Burning Rock Biotech Limited American Depositary Shares Post-ER Performance | BigEarnings
BNR — Burning Rock Biotech Limited American Depositary Shares
XNAS · Healthcare · Diagnostics & Research
Price$8.69
Market Cap$76.6M
P/E—
52W Range$2.80 – $41.72
Next Earnings2026-06-16
About Burning Rock Biotech Limited American Depositary Shares
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
